None of the cell lines expressed miR-122, similar to our previous observations with blood–brain barrier endothelial cells and HepG2-CD81 hepatoma cells that support low level HCVcc replication (Fletcher et al., 2012; Israelow et al., 2014). This evidence concerns the gene CD81 and hepatocellular carcinoma.